PT2605769T - Derivados benziquinona como modeladores da função mitocondrial - Google Patents
Derivados benziquinona como modeladores da função mitocondrialInfo
- Publication number
- PT2605769T PT2605769T PT117488981T PT11748898T PT2605769T PT 2605769 T PT2605769 T PT 2605769T PT 117488981 T PT117488981 T PT 117488981T PT 11748898 T PT11748898 T PT 11748898T PT 2605769 T PT2605769 T PT 2605769T
- Authority
- PT
- Portugal
- Prior art keywords
- mitchondrial
- treatment
- eye diseases
- benzoquinone derivatives
- benzoquinone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
- C07C50/28—Quinones containing groups having oxygen atoms singly bound to carbon atoms with monocyclic quinoid structure
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37397210P | 2010-08-16 | 2010-08-16 | |
| EP10008542 | 2010-08-16 | ||
| US201061424978P | 2010-12-20 | 2010-12-20 | |
| EP10015842 | 2010-12-20 | ||
| US201161473835P | 2011-04-11 | 2011-04-11 | |
| EP11003037 | 2011-04-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2605769T true PT2605769T (pt) | 2016-11-02 |
Family
ID=45605465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT117488981T PT2605769T (pt) | 2010-08-16 | 2011-08-16 | Derivados benziquinona como modeladores da função mitocondrial |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP2605769B1 (pt) |
| CY (1) | CY1118134T1 (pt) |
| DK (1) | DK2605769T3 (pt) |
| ES (1) | ES2588770T3 (pt) |
| HR (1) | HRP20161407T1 (pt) |
| HU (1) | HUE030595T2 (pt) |
| PL (1) | PL2605769T3 (pt) |
| PT (1) | PT2605769T (pt) |
| RS (1) | RS55173B1 (pt) |
| SI (1) | SI2605769T1 (pt) |
| SM (1) | SMT201600345B (pt) |
| WO (1) | WO2012022468A2 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2892516A1 (en) * | 2012-09-07 | 2015-07-15 | Edison Pharmaceuticals, Inc. | Quinone derivatives for use in the modulation of redox status of individuals |
| WO2018078922A1 (ja) * | 2016-10-24 | 2018-05-03 | 国立大学法人福井大学 | 白内障の予防剤、治療剤、およびこれらを製造するためのｈａｔ阻害剤の使用 |
| WO2018132610A1 (en) | 2017-01-13 | 2018-07-19 | Cellular Research, Inc. | Hydrophilic coating of fluidic channels |
| WO2018136573A1 (en) * | 2017-01-18 | 2018-07-26 | Schlumberger Technology Corporation | Non-stop circulation system for maintaining bottom hole pressure |
| EP4038076A1 (en) | 2019-10-04 | 2022-08-10 | Stealth BioTherapeutics Inc. | Chinone-, hydrochinome- and naphthochinone-analogues of vatiquione for treatment of mitochondrial disorder diseases |
| WO2021202986A1 (en) | 2020-04-03 | 2021-10-07 | Stealth Biotherapeutics Corp | Compositions and methods for the prevention and/or treatment of mitochondrial disease, including friedreich's ataxia |
| WO2021211436A1 (en) * | 2020-04-13 | 2021-10-21 | Travecta Therapeutics Pte. Ltd. | Idebenone compounds |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5919930B2 (ja) | 1974-05-02 | 1984-05-09 | 武田薬品工業株式会社 | キノン酸誘導体の製造法 |
| JPS51128932A (en) | 1975-04-30 | 1976-11-10 | Takeda Chem Ind Ltd | Organic compounds |
| JPS56150014A (en) | 1980-04-21 | 1981-11-20 | Takeda Chem Ind Ltd | Antiallergic agent |
| JPS5877839A (ja) * | 1981-11-02 | 1983-05-11 | Takeda Chem Ind Ltd | 安定な微細結晶およびその製造法 |
| EP0201196B1 (en) * | 1985-04-08 | 1991-07-03 | Takeda Chemical Industries, Ltd. | Benzoquinone derivatives, their production and use |
| EP0788793A1 (en) * | 1996-02-01 | 1997-08-13 | Takeda Chemical Industries, Ltd. | Idebenone for the treatment of dementia |
| US6271266B1 (en) * | 1996-07-11 | 2001-08-07 | Takeda Chemical Industries, Ltd. | Use of idebenone and analogues against β amyloid induced cytotoxicity |
| TWI246421B (en) | 1998-12-03 | 2006-01-01 | Alcon Mfg Ltd | Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases |
| NZ561235A (en) | 2005-03-21 | 2010-12-24 | Santhera Pharmaceuticals Ch | Idebenone for the treatment of muscular dystrophies |
| WO2006130775A2 (en) | 2005-06-01 | 2006-12-07 | Edison Pharmaceuticals, Inc. | Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomakers |
| EP1891946A1 (en) | 2006-08-14 | 2008-02-27 | Santhera Pharmaceuticals (Schweiz) AG | Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone |
| US20100099775A1 (en) | 2008-10-17 | 2010-04-22 | Alpharx Inc. | Method for ameliorating of post-anesthetic recovery |
| US20100129431A1 (en) | 2008-11-24 | 2010-05-27 | Alpharx Inc. | Idebenone composition for the treatment of neurological disorders |
| US20100130619A1 (en) | 2008-11-24 | 2010-05-27 | Joseph Schwarz | Pharmaceutical composition for parenteral administration of idebenone |
| US20100215725A1 (en) | 2009-02-20 | 2010-08-26 | Joseph Schwarz | Pharmaceutical composition containing idebenone for the treatment of liver disorders |
-
2011
- 2011-08-16 RS RS20160776A patent/RS55173B1/sr unknown
- 2011-08-16 WO PCT/EP2011/004123 patent/WO2012022468A2/en active Application Filing
- 2011-08-16 SI SI201130942A patent/SI2605769T1/sl unknown
- 2011-08-16 DK DK11748898.1T patent/DK2605769T3/en active
- 2011-08-16 PT PT117488981T patent/PT2605769T/pt unknown
- 2011-08-16 HU HUE11748898A patent/HUE030595T2/en unknown
- 2011-08-16 EP EP11748898.1A patent/EP2605769B1/en active Active
- 2011-08-16 ES ES11748898.1T patent/ES2588770T3/es active Active
- 2011-08-16 PL PL11748898T patent/PL2605769T3/pl unknown
-
2016
- 2016-10-03 SM SM201600345T patent/SMT201600345B/it unknown
- 2016-10-21 CY CY20161101059T patent/CY1118134T1/el unknown
- 2016-10-27 HR HRP20161407TT patent/HRP20161407T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012022468A3 (en) | 2012-06-28 |
| ES2588770T3 (es) | 2016-11-04 |
| EP2605769B1 (en) | 2016-07-27 |
| CY1118134T1 (el) | 2017-06-28 |
| EP2605769A2 (en) | 2013-06-26 |
| HUE030595T2 (en) | 2017-05-29 |
| WO2012022468A2 (en) | 2012-02-23 |
| SMT201600345B (it) | 2016-11-10 |
| PL2605769T3 (pl) | 2017-01-31 |
| RS55173B1 (sr) | 2017-01-31 |
| DK2605769T3 (en) | 2016-10-24 |
| HRP20161407T1 (hr) | 2016-12-02 |
| SI2605769T1 (sl) | 2016-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201208535B (en) | Formulations of quinones for the treatment of ophthalmic diseases | |
| EP2621499A4 (en) | METHODS OF TREATING ALLERGIC DISEASES | |
| ZA201403795B (en) | Formulations for the treatment of diabetes | |
| HK1201438A1 (en) | Treatment of ocular disease | |
| ZA201301601B (en) | Treatment of diseases | |
| EP2720689A4 (en) | CATÉCHOL DERIVATIVES FOR THE TREATMENT OF OXIDATIVE STRESS DISEASES | |
| EP2613786A4 (en) | TREATMENT OF DISEASES | |
| EP2623494A4 (en) | AGENT FOR THE TREATMENT OF OCULAR DISEASES | |
| PT2539352T (pt) | Composições e métodos para tratar doenças cardíacas | |
| EP2656837A4 (en) | LIPID NANOPARTICLES FOR THE TREATMENT OF OCULAR DISEASES | |
| GB0906159D0 (en) | Drug combination for the treatment of proteostatic diseases | |
| PT2605769T (pt) | Derivados benziquinona como modeladores da função mitocondrial | |
| IL225896A0 (en) | Treatment of mecp-2 related disorders | |
| ZA201208389B (en) | Treatment of proliferative diseases | |
| PL2538918T3 (pl) | Cytocholina do leczenia jaskry | |
| IL275636A (en) | Medical combination for cancer treatment | |
| PL392436A1 (pl) | Pochodne arylosulfonamidów do leczenia chorób odśrodkowego układu nerwowego | |
| IL225755A0 (en) | Amido-6 derivatives of epoxymorphinans-a5, 4 for the treatment of pain | |
| IL229791A0 (en) | Indoleamine derivatives for the treatment of diseases of the central nervous system | |
| PT2621329T (pt) | Disposição para assistência a um tratamento cirúrgico de olho | |
| ZA201400488B (en) | Compounds for the treatment of cancers associated with human papillomavirus | |
| EP2670421A4 (en) | USE OF ICAM-1 FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL DISEASES | |
| GB201003124D0 (en) | Treatment of oxidative stress disorders | |
| AU2011903764A0 (en) | Treatment of bone diseases | |
| ZA201304121B (en) | Arlysulfonamide derivatives for the prevention or treatment of specific ophthalmologic disorders |